Undurti Narasimha Das

22PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsOptical technologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Mar 02, 2026
Lipoxin A4 activates Nrf2 expression and mitigates hyperglycaemia-induced impairment of myogenesis and rescues damage to mitochondria.

Akash Mitra, Deepika Bhat K, Joel Rimson Pinto

|Feb 23, 2026
Arachidonic Acid and Lipoxin A4 Protect Pancreatic β-Cells and Improve Hyperglycemia Induced by Bleomycin.

Sailaja Polavarapu, Poorani Rhenghachar, Undurti N Das

|Nov 10, 2025
Is Sepsis an Essential Fatty Acids Deficiency State?

Undurti N Das

|Sep 15, 2025
Arachidonic Acid Protects Skeletal Muscle Against Hyperglycaemia-Induced Muscle Atrophy by Modulating Myogenesis and Regulating KLF15 Expression in C57Bl/6 Mice.

Akash Mitra, Debajit Chaudhury, Akhila Balakrishna Rai

|Aug 26, 2025
Lipoxin A4 (LXA4) as a Potential Drug for Autoimmune Uveitis

Undurti Narasimha Das

|Jul 10, 2025
Inhibition of Malate Dehydrogenase-Pyruvate-cPLA2-Reduced ROS and Recovery From Ischemia-Reperfusion Injury.

Undurti N Das

Pageof 4